Results 111 to 120 of about 1,236,946 (289)
Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi +19 more
wiley +1 more source
Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher +10 more
wiley +1 more source
Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini +28 more
wiley +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz +8 more
wiley +1 more source
STABILITY CRITERIA FOR STOCHASTIC DISCRETE-TIME FRACTIONAL ORDER SYSTEMS [PDF]
In this paper are discussed stability problems for a class of discrete-time fractional systems (DTFSs) with independent random perturbations. Two notions of mean square stability (MSS) and mean square asymptotic stability (MSAS) are introduced for the ...
Carmen BARBACIORU +1 more
doaj
A split-step theta (SST) method is introduced and used to solve the nonlinear neutral stochastic delay differential equations (NSDDEs). The mean square asymptotic stability of the split-step theta (SST) method for nonlinear neutral stochastic delay ...
Haiyan Yuan, Jihong Shen, Cheng Song
doaj +1 more source
Stability and Synchronization of Delayed Quaternion-Valued Neural Networks under Multi-Disturbances
This paper discusses a type of mixed-delay quaternion-valued neural networks (QVNNs) under impulsive and stochastic disturbances. The considered QVNNs model are treated as a whole, rather than as complex-valued neural networks (NNs) or four real-valued ...
Jibin Yang +4 more
doaj +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Numerical studies of dynamic stability under small random parametric excitations
An efficient numerical procedure is proposed to obtain mean-square stability regions for both single-degree-of-freedom and two-degree-of-freedom linear systems under parametric bounded noise excitation.
Roman V. Bobryk, Andrzej Chrzeszczyk
doaj

